Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Pharm Res. 2017 Aug 2;34(11):2349–2361. doi: 10.1007/s11095-017-2242-z

Table V.

Simulation Results for Acyclovir Following Escalating Oral Doses of Valacyclovir in Wildtype and Pept1 Knockout Mice

Genotype Dose
(nmol/g)
Cmax
(μM)
AUC0–180
(min·μmol/L)
r2
Observed Predicted Observed Predicted
Wildtype 10 3.8 3.9 278 279 0.898
25 9.6 9.7 663 691 0.969
50 20.9 19.0 1675 1364 0.902
100 40.6 35.9 2923 2636 0.875
Pept1 Knockout 10 0.9 1.0 128 131 0.897
25 1.7 1.8 235 238 0.877
50 5.0 5.2 743 687 0.814
100 8.8 8.8 1233 1176 0.885